Table 1.
Demographics Comparing Intervention and Control Groups at Baseline
| Variable | Intervention | Controls |
|---|---|---|
| Abbreviation: FEV1, forced expiratory volume in 1 second. | ||
| No. of subjects | 12 | 6 |
| Median age (range), y | 9 (6–14) | 7 (6–10) |
| No. (%) of boys | 7 (58) | 2 (33) |
| Type of dwelling, No. (%) | ||
| Single | 3 (25) | 1 (17) |
| Apartment | 3 (25) | 2 (33) |
| Row or duplex | 6 (50) | 3 (50) |
| Race, No. (%) | ||
| White | 1 (8) | 1 (17) |
| Black | 8 (67) | 2 (33) |
| Hispanic | 3 (25) | 3 (50) |
| No. (%) with ≥ 3 other positive skin test results | 10 (83) | 5 (83) |
| No. (%) with positive cockroach skin test result | 5 (42) | 3 (50) |
| Median inhaled fluticasone dose (range), μg* | 198 (176–440) | 176 (176–440) |
| Percentage of predicted FEV1 (range) | 77 (70–105) | 81 (70–120) |
*
One child in the intervention group was taking 400 μg/d of inhaled budesonide.